E

Emergent Biosolutions
D

EBS

9.40000
USD
0.53
(5.98%)
Market Closed
Volume
32,004
EPS
2
Div Yield
-
P/E
-1
Market Cap
497,322,266
OverviewSignalsIdeasNews
Related Instruments
    C
    CBOE
    2.040
    (1.03%)
    200.880 USD
    CME
    CME
    1.845
    (0.83%)
    225.275 USD
    G
    GNK
    -0.107
    (-0.60%)
    17.660 USD
    H
    HAL
    -0.440
    (-1.46%)
    29.690 USD
    ICE
    ICE
    -0.920
    (-0.59%)
    155.530 USD
    NDAQ
    NDAQ
    0.770
    (0.99%)
    78.770 USD
    N
    NG
    -0.09000
    (-2.58%)
    3.40000 USD
    O
    OFG
    -0.310
    (-0.70%)
    43.770 USD
    More
News

Title: Emergent Biosolutions

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.